You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API iptacopan

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing iptacopan

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	FABHALTA	iptacopan	0078-1189	AMMONIA	2030-12-05
Novartis Pharmaceuticals Corporation	FABHALTA	iptacopan	0078-1189	FERRIC OXIDE RED	2030-12-05
Novartis Pharmaceuticals Corporation	FABHALTA	iptacopan	0078-1189	FERRIC OXIDE YELLOW	2030-12-05
Novartis Pharmaceuticals Corporation	FABHALTA	iptacopan	0078-1189	FERROSOFERRIC OXIDE	2030-12-05
Novartis Pharmaceuticals Corporation	FABHALTA	iptacopan	0078-1189	GELATIN	2030-12-05
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for iptacopan

Excipient focus: AMMONIA

iptacopan drug variants containing AMMONIA

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing AMMONIA

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

iptacopan drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

iptacopan drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

iptacopan drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

iptacopan drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POTASSIUM HYDROXIDE

iptacopan drug variants containing POTASSIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing POTASSIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

iptacopan drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

iptacopan drug variants containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

iptacopan drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	iptacopan	0078-1189
>Company	>Ingredient	>NDC

iptacopan drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.